Posts by: Ana Pamplona, PhD

News

Researchers from the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have identified specific enzymes called protein kinases that participate in critical steps of bone and ... Read more

March 25, 2015March 25, 2015

Vitamin D Acts As Biological “Brake” For Low-Grade Prostate Cancer

News

During the 249th National Meeting & Exposition of the American Chemical Society (ACS), the largest scientific society worldwide held in Denver, Colorado between 22nd and 26th of March, Dr. Bruce ... Read more

March 10, 2015March 10, 2015

Researchers Report New Findings on Metastatic Castration-Resistant Prostate Cancer Treatment Resistance

News

A recent study on metastatic castration-resistant prostate cancer (mCRPC) showed that androgen receptor V7 (or AR-V7) status has no significant impact on the response to taxane chemotherapy. The study entitled ... Read more

February 24, 2015February 24, 2015

Benefits of Cabazitaxel in Advanced Stages of Prostate Cancer

News

A recent study entitled “Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer” published in Clinical Cancer Research showed that cabazitaxel, a new member of the taxane family and ... Read more

February 20, 2015February 20, 2015

Prostate Cancer Therapy Targets Cancer Stem Cell Antigen

News

In a recent study entitled “Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM,” published in BMC Immunology by Zhenling Deng and colleagues from the Department ... Read more

January 5, 2015January 5, 2015

Experts Review The Role of Follicle-Stimulating Hormone in Prostate Cancer

News

A review about the potential role of follicle-stimulating hormone (FSH) in the development and progression of prostate cancer entitled “The Role of the FSH System in the Development and Progression of ... Read more

December 23, 2014December 23, 2014

Researchers Developed A Novel Class Of Synthetic Molecules That Target Prostate Cancer Cells

News

A novel class of synthetic molecules with the targeting and effector functions of antibodies were synthesized to induce a highly targeted immune response against prostate cancer. The study entitled “Chemically ... Read more

October 22, 2014October 22, 2014

Obesity May Increase Risk of Progression For patients With Low-Risk Prostate Cancer

News

A new study on the association between obesity and prostate cancer entitled “Obesity Is Associated with Risk of Progression for Low-risk Prostate Cancers Managed Expectantly” was published in the European Urology Journal by ... Read more

September 30, 2014September 30, 2014

Aspirin May Reduce Risk of Aggressive Prostate Cancer

News

A new study assessing the effect of Aspirin in decreasing prostate cancer risk will be presented at the 13th Annual American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held in ... Read more

September 30, 2014September 30, 2014

Higher Prostate Cancer Incidence in the U.S. Leads to Accelerated Drug development Efforts

News

Cancer is one of the most deadly diseases in the world, with a mortality of 8.2 million people in 2012, as reported by the World Health Organization (WHO). A recent WHO ... Read more